Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078583HIVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009148HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009386HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20059821HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS44038999HTLV-1ENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TCGA Plot Options
Drug Information
GeneHRH2
DrugBank IDDB00797
Drug NameTolazoline
Target IDBE0000112
UniProt IDP25021
Regulation Typeagonist
PubMed IDs6386273; 21948594; 8487790
CitationsWard RM: Pharmacology of tolazoline. Clin Perinatol. 1984 Oct;11(3):703-13.@@Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP: ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.@@Roll C, Hanssler L: [Interaction of tolazoline and cimetidine in persistent fetal circulation of the newborn infant]. Monatsschr Kinderheilkd. 1993 Apr;141(4):297-9.
GroupsApproved; Vet_approved
Direct ClassificationBenzene and substituted derivatives
SMILESC(C1=NCCN1)C1=CC=CC=C1
Pathways
PharmGKBPA451716
ChEMBLCHEMBL770